GLP-1 (glucagon-like peptide-1) medications are FDA-approved prescription drugs that mimic a natural hormone regulating appetite and metabolism
Some patients who experienced mood fluctuations on daily liraglutide report more stable mood on weekly tirzepatide, likely due to the steadier drug levels
If you are thinking about it you should try it its really worth your money
The headline results, as released in the Eli Lilly investor communication and aligned with the study design paper by Giblin and colleagues published in Diabetes, Obesity and Metabolism in 2026, are unusually strong for a Phase 3 obesity trial: Retatrutide 12 mg: mean body-weight reduction of 28.7 percent, roughly 32.3 kg (about 71.2 lbs) from baseline
Through glutathione S-transferase (GST) enzymes, GSH can conjugate (bind) to certain reactive metabolites and environmental compounds, making them more water-soluble and easier for the body to eliminate
Across the evaluated dose pairs, high posterior probabilities of clinical equivalence were observed for semaglutide 2.4 mg versus tirzepatide 10 mg and semaglutide 7.2 mg versus tirzepatide 15 mg, suggesting that similar weight-loss outcomes can be achieved with these dose combinations
